Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vickers Vantage Corp. I | 250,000 | reported | 17 Jan 2023 | tx 1+250,000 |
| Aardvark Therapeutics, Inc. | 203,851 | reported | 09 Feb 2026 | tx 15+662,817−572,291 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | GRANT_AWARD | Aardvark Therapeutics, Inc. | 203,851 | 0.00 USD | deriv |
| 11 Dec 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 7,000 | 14.49 USD | |
| 15 Oct 2025 | EXERCISE | Aardvark Therapeutics, Inc. | 1,229 | 4.24 USD | |
| 15 Oct 2025 | EXERCISE | Aardvark Therapeutics, Inc. | 1,229 | 0.00 USD | deriv |
| 15 Sept 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 6,500 | 9.51 USD | |
| 15 Sept 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 3,500 | 9.94 USD | |
| 11 Sept 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 6,000 | 7.82 USD | |
| 10 Sept 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 9,000 | 7.91 USD | |
| 12 Sept 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 5,000 | 8.50 USD | |
| 28 Aug 2025 | EXERCISE | Aardvark Therapeutics, Inc. | 17,209 | 4.24 USD | |
| 28 Aug 2025 | EXERCISE | Aardvark Therapeutics, Inc. | 17,209 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Aardvark Therapeutics, Inc. | 549,534 | 0.00 USD | deriv |
| 14 Feb 2025 | PURCHASE | Aardvark Therapeutics, Inc. | 16,542 | 16.00 USD | |
| 14 Feb 2025 | CONVERSION | Aardvark Therapeutics, Inc. | 41,303 | — | |
| 14 Feb 2025 | CONVERSION | Aardvark Therapeutics, Inc. | 350,002 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Vickers Vantage Corp. I | 250,000 | 0.00 USD | deriv |